AVR
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Anteris received French regulatory clearance supporting expansion of the global PARADIGM trialJun 8, 2026
- Anteris Technologies treated the first U.S. patients in the global PARADIGM pivotal trialMay 5, 2026
- Anteris Technologies presented data from 100 DurAVR® THV patients at PCR London ValvesNov 17, 2025
- Anteris Technologies announces first patients treated in DurAVR® THV global pivotal trial (the "PARADIGM Trial")Oct 28, 2025
- Anteris receives first European regulatory clearance to commence DurAVR® THV global pivotal trial (the PARADIGM Trial)Oct 15, 2025